Healthcare & Life Sciences
Ribon Therapeutics
Israel
Ribon Therapeutics is a seed startup based in United States. 1 investor tracked.
Activeseries-b
series-b
Stage
2018
Founded
1
Investors
About Ribon Therapeutics
Ribon Therapeutics is a startup founded in 2018 based in Israel. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ribon Therapeutics is a clinical-stage biotechnology company developing selective small molecule inhibitors targeting NAD+-utilizing enzymes activated under cellular stress conditions to treat diseases with limited therapeutic options.
Explore Ribon Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.